Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer

[1]  Marco Marc Lianne Marco J Djuna L Thomas M Jeanin E Mark Del Chiaro Besselink Scholten Bruno Cahen G.  European evidence-based guidelines on pancreatic cystic neoplasms , 2018, Gut.

[2]  F. Real,et al.  A genetic roadmap of pancreatic cancer: still evolving , 2017, Gut.

[3]  H. Völzke,et al.  Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study , 2017, Gut.

[4]  J. Cameron,et al.  Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas , 2017, Annals of surgery.

[5]  R. Schmid,et al.  Atypical flat lesions derive from pancreatic acinar cells. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[6]  M. Büchler,et al.  Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial , 2017, The Lancet.

[7]  Gun Ho Jang,et al.  A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns , 2016, Nature.

[8]  C. Schmidt,et al.  Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm. , 2016, Advances in surgery.

[9]  A. Gerdes,et al.  Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[10]  A. Carrato,et al.  Refinement of screening for familial pancreatic cancer , 2016, Gut.

[11]  M. Falconi,et al.  Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  N. Malats,et al.  PanGen-Fam: Spanish registry of hereditary pancreatic cancer. , 2015, European journal of cancer.

[13]  V. Lemmens,et al.  Changes in gastrointestinal cancer resection rates , 2015, The British journal of surgery.

[14]  G. Capurso,et al.  Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals. , 2015, World journal of gastrointestinal endoscopy.

[15]  M. Hidalgo,et al.  Pancreatic cancer: from state-of-the-art treatments to promising novel therapies , 2015, Nature Reviews Clinical Oncology.

[16]  A. Andrén-sandberg,et al.  Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer. , 2015, JAMA surgery.

[17]  D. Gouma,et al.  A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals , 2015, Gut.

[18]  M. Catalano,et al.  Promising Outcomes of Screening for Pancreatic Cancer by Genetic Testing and Endoscopic Ultrasound , 2014, Pancreas.

[19]  D. Jäger,et al.  Improvement of surgical results for pancreatic cancer. , 2013, The Lancet. Oncology.

[20]  U. Boggi,et al.  Risk Factors for Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: A Multicentre Case–Control Study , 2013, The American Journal of Gastroenterology.

[21]  A. Klein.  Identifying people at a high risk of developing pancreatic cancer , 2012, Nature Reviews Cancer.

[22]  J. Heverhagen,et al.  Variation in Precursor Lesions of Pancreatic Cancer among High-Risk Groups , 2012, Clinical Cancer Research.

[23]  Paul Fockens,et al.  International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer , 2012, Gut.

[24]  Jin‐Young Jang,et al.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[25]  Zhe Zhang,et al.  Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. , 2012, Gastroenterology.

[26]  M. Haider,et al.  Screening for Pancreatic Cancer in a High-Risk Cohort: An Eight-Year Experience , 2012, Journal of Gastrointestinal Surgery.

[27]  Joshua A. Waters,et al.  Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage. , 2011, Journal of the American College of Surgeons.

[28]  G. Badger,et al.  Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study. , 2011, Gastrointestinal endoscopy.

[29]  W. Jarnagin,et al.  Feasibility and Yield of Screening in Relatives From Familial Pancreatic Cancer Families , 2011, The American Journal of Gastroenterology.

[30]  R. Tollenaar,et al.  Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. , 2011, Gastroenterology.

[31]  V. Fendrich,et al.  German national case collection for familial pancreatic cancer (FaPaCa): ten years experience , 2011, Familial Cancer.

[32]  Carolyn D Sy,et al.  Pancreatic Cancer Screening in a Prospective Cohort of High-Risk Patients: A Comprehensive Strategy of Imaging and Genetics , 2010, Clinical Cancer Research.

[33]  D. Gouma,et al.  The Yield of First-Time Endoscopic Ultrasonography in Screening Individuals at a High Risk of Developing Pancreatic Cancer , 2009, The American Journal of Gastroenterology.

[34]  J. Heverhagen,et al.  Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer , 2009, Gut.

[35]  W. Bamlet,et al.  Long-Term Survival and Prognostic Indicators in Small (≤2 cm) Pancreatic Cancer , 2008, Pancreatology.

[36]  Laura K. Bianchi,et al.  Fundic gland polyp dysplasia is common in familial adenomatous polyposis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  R. Hruban,et al.  Advances in counselling and surveillance of patients at risk for pancreatic cancer , 2007, Gut.

[38]  Giovanni Parmigiani,et al.  PancPRO: risk assessment for individuals with a family history of pancreatic cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Cameron,et al.  Multifocal Neoplastic Precursor Lesions Associated With Lobular Atrophy of the Pancreas in Patients Having a Strong Family History of Pancreatic Cancer , 2006, The American journal of surgical pathology.

[40]  E. Fishman,et al.  Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  W. Greenhalf,et al.  Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. , 2005, Gastroenterology.

[42]  Steven Piantadosi,et al.  Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  J. Kleibeuker,et al.  Surveillance for Hereditary Nonpolyposis Colorectal Cancer , 2002 .

[44]  M. Kimmey,et al.  Screening and surveillance for hereditary pancreatic cancer. , 2002, Gastrointestinal endoscopy.

[45]  M. Kimmey,et al.  Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer , 1999, Annals of Internal Medicine.

[46]  W. Greenhalf,et al.  Single-Nucleotide Polymorphism to Associate Cancer Risk. , 2016, Methods in molecular biology.

[47]  W. Greenhalf,et al.  Familial pancreatic cancer: a review and latest advances. , 2007, Advances in medical sciences.